Literature DB >> 16807783

Angiogenic patterns and their quantitation in high grade astrocytic tumors.

Suash Sharma1, Mehar C Sharma, Deepak Kumar Gupta, Chitra Sarkar.   

Abstract

BACKGROUND: The objectives of this study on high grade astrocytic tumors were (i) to establish differences, if any, between grades III & IV tumors among angiogenic parameters, both qualitative and quantitative, and (ii) to correlate angiogenic parameters with proliferation indices, namely T2a and MIB1 labeling indices.
DESIGN: Twenty nine consecutive cases of WHO grades III (11) and IV (18) astrocytic tumors diagnosed in the year-2004 were studied, using H&E and CD34, MIB1 and T2a immunostaining by streptavidin biotin technique. Angiogenic patterns were studied and parameters quantitated using Image Pro Plus software (four hotspots) on CD34 immunostained sections to determine intratumoral microvessel density (iMVD), microvascular area (MVA), aspect, mean diameter (MD) and fractal dimension (FD).
RESULTS: Main angiogenic patterns of capillary (18) and glomeruloid (9) types were best developed in glioblastomas. Statistically significant differences (P<0.05) were seen between grades III and IV in iMVD, aspect, MD and FD, but not in angiogenic patterns or MVA (P = 0.27). Statistically significant differences (P<0.05) were seen between glioblastomas with glomeruloid vs. capillary types in iMVD and FD, but not in MVA, aspect and mean vessel diameter. T2a values correlated with MIB1 labeling indices (R = 0.965, P<0.001). Intratumoral endothelial MIB1 LI was significantly higher in grade IV as compared to grade III, but did not correlate with angiogenic parameters. No correlation of angiogenic patterns and proliferation indices was noted (R = -0.221, P = 0.26). Limited follow up data showed all recurrent grade IV tumors to be of glomeruloid type.
CONCLUSION: Increased angiogenesis in grade IV, as compared to grade III, astrocytic tumors is characterized by an increased number/density of vessels: an increase in vessels characterized by disproportionate lengthening and likely associated with the infiltrative properties of the tumors; and an increase in pliable, irregularly shaped or structured vessels. In addition, there is a greater frequency of glomeruloid structures indicating inadequate directional migration of the newly formed vessels. The lack of correlation of these angiogenesis parameters with the MIB1 and T2a proliferation indices reflects the complexity of angiogenesis parameters in high grade gliomas. Further studies are needed to determine the usefulness of the angiogenic parameters in the improved diagnosis (grading) and prognosis of astrocytic tumors.

Entities:  

Mesh:

Year:  2006        PMID: 16807783     DOI: 10.1007/s11060-006-9120-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  46 in total

1.  Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy.

Authors:  P Wesseling; J A van der Laak; M Link; H L Teepen; D J Ruiter
Journal:  Hum Pathol       Date:  1998-04       Impact factor: 3.466

2.  The vascular response to tumor infiltration in malignant gliomas. Morphometric and reconstruction study.

Authors:  D Schiffer; A Chiò; M T Giordana; A Mauro; A Migheli; M C Vigliani
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.

Authors:  A E Konstantinidou; E Patsouris; P Korkolopoulou; N Kavantzas; H Mahera; P Davaris
Journal:  Histopathology       Date:  2001-10       Impact factor: 5.087

4.  [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].

Authors:  Lin Xiao; Liang-Dan Tang
Journal:  Ai Zheng       Date:  2005-01

Review 5.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

6.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

7.  The role of vascular proliferation in the growth of brain tumors.

Authors:  S Brem
Journal:  Clin Neurosurg       Date:  1976

8.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

Authors:  W J Curran; C B Scott; J Horton; J S Nelson; A S Weinstein; A J Fischbach; C H Chang; M Rotman; S O Asbell; R E Krisch
Journal:  J Natl Cancer Inst       Date:  1993-05-05       Impact factor: 13.506

Review 9.  Molecular mechanisms of developmental and tumor angiogenesis.

Authors:  K H Plate; G Breier; W Risau
Journal:  Brain Pathol       Date:  1994-07       Impact factor: 6.508

10.  Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).

Authors:  J P Dales; S Garcia; S Carpentier; L Andrac; O Ramuz; M N Lavaut; C Allasia; P Bonnier; C Taranger-Charpin
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

View more
  15 in total

1.  Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Z Xing; R X You; J Li; Y Liu; D R Cao
Journal:  Clin Neuroradiol       Date:  2013-08-31       Impact factor: 3.649

2.  Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.

Authors:  Eric S Paulson; Kathleen M Schmainda
Journal:  Radiology       Date:  2008-09-09       Impact factor: 11.105

3.  Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.

Authors:  Mei Liu; Yong Lin; Xian-Chao Zhang; Yu-Huan Tan; Yue-Liang Yao; Juan Tan; Xia Zhang; You-Hong Cui; Xindong Liu; Yan Wang; Xiu-Wu Bian
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

Review 4.  Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.

Authors:  Sarah J Nelson
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

5.  Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade.

Authors:  R Jain; S K Ellika; L Scarpace; L R Schultz; J P Rock; J Gutierrez; S C Patel; J Ewing; T Mikkelsen
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

6.  Comparison of multiple parameters obtained on 3T pulsed arterial spin-labeling, diffusion tensor imaging, and MRS and the Ki-67 labeling index in evaluating glioma grading.

Authors:  H Fudaba; T Shimomura; T Abe; H Matsuta; Y Momii; K Sugita; H Ooba; T Kamida; T Hikawa; M Fujiki
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-03       Impact factor: 3.825

Review 7.  Susceptibility-weighted imaging: technical aspects and clinical applications, part 2.

Authors:  S Mittal; Z Wu; J Neelavalli; E M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-08       Impact factor: 3.825

8.  Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR.

Authors:  Carlos A Scrideli; Carlos G Carlotti; Oswaldo K Okamoto; Vanessa S Andrade; Maria A A Cortez; Fábio J N Motta; Agda K Lucio-Eterovic; Luciano Neder; Sérgio Rosemberg; Sueli M Oba-Shinjo; Suely K N Marie; Luíz G Tone
Journal:  J Neurooncol       Date:  2008-04-09       Impact factor: 4.130

9.  CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.

Authors:  Xing-Gang Mao; Xiao-Yan Xue; Liang Wang; Xiang Zhang; Ming Yan; Yan-Yang Tu; Wei Lin; Xiao-Fan Jiang; Hong-Gang Ren; Wei Zhang; Shao-Jun Song
Journal:  Neuro Oncol       Date:  2013-05-03       Impact factor: 12.300

Review 10.  GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity.

Authors:  Alenoush Vartanian; Sanjay K Singh; Sameer Agnihotri; Shahrzad Jalali; Kelly Burrell; Kenneth D Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2014-03-18       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.